➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Harvard Business School
McKinsey
Boehringer Ingelheim
Moodys

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Patent: 4,936,301

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 4,936,301
Title: Electrosurgical method using an electrically conductive fluid
Abstract:An electrolyte fluid purging electrosurgical device for use with an electrode holder connected to an electrical power source and to a source of a non-electrically conductive fluid and a method of use are disclosed. The fluid purging electrosurgical device enables electrosurgery at a surgical site where an area proximate the surgical site is surrounded by an electrically conductive fluid such as saline irrigation fluids, body fluids, certain injectables and the like. The fluid purging electrosurgical device comprises an electrode shaft with an electrode shaft connector electrically connecting a first end of the electrode shaft to an electrode holder. An insulating material provides electrical insulation between a second end of the electrode shaft and the electrode holder. The insulating material is positioned on the electrode shaft to expose a portion of the second end of the electrode shaft to define an electrode tip to provide electrical current to the surgical site. A duct means is connected to the source of the non-electrically conductive fluid and extends along the electrode shaft to deliver the non-electrically conductive fluid to a region immediately proximate the electrode tip to displace the electrically conductive fluid at the position of the electrode tip in the surgical site to enable electrosurgical treatment thereat.
Inventor(s): Rexroth; Frederick W. (Dunedin, FL), Bays; F. Barry (Seminole, FL)
Assignee: Concept, Inc. (Clearwater, FL)
Application Number:07/065,823
Patent Claims:see list of patent claims

Details for Patent 4,936,301

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial Concept, Inc. (Clearwater, FL) 2039-09-23 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial Concept, Inc. (Clearwater, FL) 2039-09-23 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Dow
Moodys
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.